International Vaccine Institute
Seoul, Korea, Republic of
Purpose
to reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics
Division
Global Health
Date
October 2009
Region Served
GLOBAL
Committed amount
$13,430,938
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
99
Grantee location
Seoul, Korea, Republic of
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.